Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 101-106

  Guo, Qing ^a   Fu, Weiming ^a   Sopher, Bryce L ^b   Miller, Miles W ^b   Ware, Carol B ^b   Martin, George M ^b   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANTROLENE; GLUTAMIC ACID; NIFEDIPINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CHROMOSOME 14; GENE LOCATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PRESENILIN-1;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0033016172     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4789     Document Type: Article

References (30)

1. Olney, J. W. & DeGubareff, T. Glutamate and the pathophysiology of hypotoxicishemic brain damage. Ann. Neurol. 271, 557-559 (1978).
2. Choi, D.W. Calcium: still center stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18, 58-60 (1996).
3. Greenamyre, J.T. & Young, A.B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging 10, 593-602 (1989).
4. Mattson, M.P. et al. β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415 (1993).
5. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159 (1997).
6. Kim, T.W. & Tanzi, R.E. Presenilins and Alzheimer's disease. Curr. Opin. Neurobiol. 7, 683-688 (1997).
7. Zhou, Q., Quaife, C.J. & Palmiter, R.Î. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholoamines are required for mouse fetal development. Nature 374, 640-643 (1995).
8. Nagy, A. et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428 (1993).
9. Guo, Q. et al. Alzheimer's presenilin mutation sesnsitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222 (1997).
10. Guo, Q., Christakos, S., Robinson, N. & Mattson, M.P. Calbindin blocks the proapoptotic actions of mutant presenilin-1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. USA 95, 3227-3232 (1998).
11. Scheuner, D. et al. The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
12. Borchelt, D.R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1 -42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996).
13. Duff, K. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713 (1996).
14. Wong, P.C. et al. Presenilin 1 is required for Notch1 and D//1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997).
15. Shen, J. et al. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997).
16. Qian, S. et al. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression. Neuron 20, 611-617 (1998).
17. Davis, J.A. et al. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20, 603-609 (1998).
18. Bruce, A. J. et al. Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors. Nature Med. 2, 788-794 (1996).
19. White, R.J. & Reynolds, I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16, 5688-5697 (1996).
20. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751 (1995).
21. Mattson, M.P. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4, 105-117 (1990).
22. Koh, J., Yang, L.L. & Cotman, C.W. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320 (1990).
23. Mattson, M. P. et al. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389 (1992).
24. Mattson, M.P. et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254 (1993).
25. Ancolio, K., Marambaud, P., Dauch, P. & Checler, F. α-secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69, 2494-2499 (1997).
26. Guo, Q., Robinson, N. & Mattson, M.P. Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis J. Biol. Chem. 273, 12341-12351 (1998).
27. Wolozin, B. et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713 (1996).
28. Grynkiewicz, G., Poenie, M. & Tsien, R.Y. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
29. Keller, J.N. et al. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18, 4439-4450 (1998).
30. Goodman, Y. & Mattson, M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid b-peptide toxicity. J. Neurochem. 66, 869-872 (1996).